Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04725474
Title First-in-Human Study of the GDF-15 Neutralizing Antibody CTL-002 in Patients With Advanced Cancer (GDFATHER) (GDFATHER)
Acronym GDFATHER
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors CatalYm GmbH
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP | DEU | CHE

Facility Status City State Zip Country Details
Universitätsklinikum Essen, Westdeutsches Tumorzentrum, Innere Klinik und Poliklinik Essen 45147 Germany Details
Universitätsklinikum Frankfurt, Medizinische Klinik I Frankfurt am Main 60590 Germany Details
Universitätsklinikum Würzburg, Comprehensive Cancer Center Würzburg 97078 Germany Details
Next Oncology, Phase I Unit. IOB - Hospital Quironsalud Barcelona 08023 Spain Details
Hospital Universitari Vall d'Hebron, Institute of Oncology Barcelona 08035 Spain Details
ICMDiM, Hospital Clinic Barcelona 08036 Spain Details
ICO Hospitalet, Hospital Duran i Reynals Barcelona 08908 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
START Madrid, Hospital Universitario HM Sanchinarro Madrid 28050 Spain Details
Clinica Universidad de Navarra, Unidad Central de Ensayos Clinicos Pamplona 31008 Spain Details
University Hospital Basel, Department for Medical Oncology Basel 4031 Switzerland Details
Kantonsspital St. Gallen, Clinic for Medical Oncology & Hematology Saint Gallen 9007 Switzerland Details
University Hospital Zurich, Department of Dermatology Zurich 9091 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field